The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 39.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it buy, with a mean price target of $3292.
XL Axiata
EXCL.JK · IDX · IDR · Market cap $46.77T · 2,891 employees
PT XLSMART Telecom Sejahtera Tbk, together with its subsidiaries, provides telecommunication, telecommunications network, and multimedia services for consumers and businesses in Indonesia.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 08:09 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price1,495.00 IDR at the 13 Nov 2026 close
- Fair valueUnder review: our model's value is 2.41x the price, above our 2.00x limit.
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-13).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
XL Axiata holds its Distribution at $1,495.00. Consolidating, no directional conviction, held for 19 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 19 days |
| Price at the screen | $1,495.00 |
| Valuation | N/A trailing · 14.89 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | -0.15 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 54.48% | Below 33% | Interest-bearing debt is 54.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 6.66% | Below 49% | Money owed to the company is 6.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.23% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
XL Axiata's business is in a permissible area, but its interest-bearing debt is about 54% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when EXCL.JK's ethical verdict changes
Today EXCL.JK does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. Our model's value is 2.41x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets: 21 covering, consensus Buy. The average target sits +134% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 14.9xcheap for a company growing this fast |
| EPS, trailing | -336.93 |
| EPS, forward | 167.89 |
| Revenue growth | +37.4%strong top-line growth |
| Profit margin | -12.1%currently unprofitable |
| Return on equity | -20.1%not currently earning a positive return on equity |
| Dividend yield | 6.19% |
| Debt to equity | 2.09heavy leverage: higher risk if revenue softens |
| Beta | -0.15barely tracks the market's swings |
| 52-week range | 2,180.00 - 4,550.00 |
| Market cap | $46.77T |
| Employees | 2,891 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Indonesia and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeEXCL.JK trades on IDX (the company is based in Indonesia). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it buy, with a mean price target of $3292.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it buy, with a mean price target of $3292.
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it buy, with a mean price target of $3292.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it buy, with a mean price target of $3292.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it buy, with a mean price target of $3292.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (21 analysts) rates it buy, with a mean price target of $3292.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $3,020.00 | -15.9% | · | $841 | -15.9% |
| 2 months | $3,160.00 | -19.6% | · | $804 | -19.6% |
| 3 months | $2,820.00 | -9.9% | · | $901 | -9.9% |
| 6 months | $3,790.00 | -33.0% | · | $670 | -33.0% |
| 1 year | $2,058.80 | +23.4% | $159.00 | $1,311 | +31.1% |
| 2 years | $2,023.99 | +25.5% | $244.70 | $1,376 | +37.6% |
| 3 years | $1,825.57 | +39.1% | $293.30 | $1,552 | +55.2% |
| 5 years | $2,200.90 | +15.4% | $386.30 | $1,330 | +33.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever EXCL.JK does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.